Skip to main content
EDEN RESEARCH PLC logo

EDEN RESEARCH PLC — Investor Relations & Filings

Ticker · EDEN ISIN · GB0001646941 LEI · 213800ZWTYTVQQSM3J85 IL Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2017-06-30 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL EDEN

About EDEN RESEARCH PLC

https://www.edenresearch.com/

Eden Research plc develops and supplies sustainable biopesticides and plastic-free encapsulation technologies. The company's core innovation is its proprietary Sustaine® microencapsulation system, which protects and delivers naturally occurring, plant-based active ingredients known as terpenes. Its products serve three primary markets: crop protection, animal health, and consumer products. The crop protection portfolio includes the biofungicide Mevalone® and the bionematicide Cedroz®, designed for applications such as foliar disease control, soil pest management, and post-harvest treatments. In animal health and consumer goods, its technologies are used in products like shampoos, flea and tick control, deodorants, and head-lice treatments.

Recent filings

Filing Released Lang Actions
Sipcam agreements, investment and proposed placing
Share Issue/Capital Change Classification · 99% confidence The document is an announcement released via RNS (RNS Number : 6692J) on June 30, 2017. It details several corporate actions: signing new commercial agreements with Sipcam, proposing an institutional placing and a subscription (fundraising activity), and providing updates on product commercialization. The key elements are the announcement of a proposed capital raise (Placing and Subscription) and significant commercial/strategic partnership expansion. This combination of fundraising and major business updates strongly suggests a Capital/Financing Update (CAP). While it involves an institutional placing, which is a financing activity, it is more comprehensive than just a simple share issue announcement (SHA) and is tied directly to strategic commercial expansion. It is not a full 10-K, an ER, or an IR. Since it explicitly details the proposal to raise c.£2.4m through a subscription and placing, 'CAP' is the most appropriate classification.
2017-06-30 English
New terms agreed with UMMS
Legal Proceedings Report Classification · 99% confidence The document begins with an 'RNS Number' and is dated June 29, 2017. It announces an agreement regarding license terms and minimum royalties with the University of Massachusetts Medical School (UMMS). The text explicitly states, 'This Announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 ("MAR"). Upon the publication of this announcement, this inside information is now considered to be in the public domain.' The document concludes with the standard footer: 'This information is provided by RNS The company news service from the London Stock Exchange END'. This structure is characteristic of a general regulatory news service announcement, which fits the definition of Regulatory Filings (RNS), as it is a broad announcement of a material event that doesn't fit the more specific categories like ER, 10-K, or DIV.
2017-06-29 English
Full accounts made up to 2016-12-31
Regulatory Filings
2017-06-28 English
Posting of Annual Report & Notice of AGM
AGM Information Classification · 98% confidence The document text explicitly states: 'Posting of Annual Report & Notice of AGM' and mentions that the 'Annual Report and Accounts for the year ended 31 December 2016, Notice of the Annual General Meeting ("AGM") and a Form of Proxy have been posted to shareholders and are now available on the Company's website'. This indicates the document is an announcement about the availability of the Annual Report and the AGM notice, rather than the full report itself (which would likely be a 10-K or AR). Since it announces the publication of reports and includes an RNS number, it fits the definition of a Report Publication Announcement (RPA). The document length (4283 chars) is also consistent with a short announcement rather than a full annual report.
2017-06-05 English
Final Results
Earnings Release Classification · 95% confidence The document explicitly states it announces the "preliminary results for the year ended 31 December 2016." It contains detailed financial highlights (Revenue, Operating loss, Loss per share) and operational highlights for the full year, which are characteristic of an Annual Report or a preliminary announcement preceding the full 10-K filing. Since it is a preliminary announcement of *final* results for the year, it functions as an Earnings Release (ER) or a precursor to the full Annual Report (10-K). Given the depth of financial data and the context of being the 'final results' for the year, it aligns most closely with the comprehensive nature of an Annual Report, even if presented as a preliminary release. However, in regulatory filing contexts, a preliminary announcement of full-year results often serves the function of an Earnings Release (ER) if it is a brief summary, or it is the content that will be incorporated into the 10-K. Since the document is quite long (over 100k characters) and contains detailed Chairman's and CEO's reports discussing strategy and financials for the entire year, it is more comprehensive than a typical quarterly Earnings Release (ER). It is not a 10-K itself, as it is dated May 2017 and refers to the year ended Dec 2016, suggesting it is the preliminary announcement of the annual results. In many classification schemes, the preliminary announcement of annual results is classified as an Earnings Release (ER) if it precedes the 10-K, or sometimes as a standalone Annual Report (AR) if it contains the full audited statements (though this one says 'preliminary'). Given the options, and the fact that it summarizes the full year's performance, it is a strong candidate for ER or AR. Since it is the *final* results announcement for the *year*, it is the primary disclosure of annual performance, making it functionally closest to the content of an Annual Report (10-K) or a detailed Audit Report (AR). Because it is a preliminary announcement of the full year's results, and not a quarterly report (IR), the best fit among the provided options that covers full-year performance disclosure is AR (Audit Report / Information), as it details the results of the past year's performance, even if it's not the formal audit opinion itself. If 'Annual Report' (10-K) was used for preliminary filings, that would be better, but 10-K is defined as the 'Official yearly report'. Given the content is the *final results* announcement for the year, it is a comprehensive annual disclosure. I will classify it as AR, as it is a detailed report of annual financial results, distinct from a quarterly report (IR) or a brief earnings release (ER). The RNS number suggests it was also filed via RNS, but the content is clearly the annual results disclosure. FY 2016
2017-05-22 English
Eden Research on BBC Radio 4's You & Yours
Regulatory Filings Classification · 99% confidence The document is explicitly marked with an 'RNS Number' and states, 'The following announcement has been released via RNS Reach, an investor communication service aimed at assisting listed and unlisted companies to distribute non-regulatory news releases such as marketing messages, corporate and product information into the public domain.' The content describes a media feature (BBC Radio 4) about one of the company's products, which is general corporate/product information rather than a mandatory financial filing (like 10-K, ER, or IR). Since it is a general regulatory announcement distributed via the RNS system that doesn't fit a more specific category (like DIRS, DIV, or CAP), the most appropriate classification is the general regulatory announcement fallback category.
2017-05-11 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.